Co-Authors
This is a "connection" page, showing publications co-authored by Carlo Lombardi and Francesco Menzella.
Connection Strength
0.257
-
Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life. Pulm Pharmacol Ther. 2019 02; 54:87-89.
Score: 0.200
-
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey. Allergy. 2021 03; 76(3):871-874.
Score: 0.056